Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$7.12 - $20.24 $3.71 Million - $10.5 Million
521,191 Added 2027.98%
546,891 $10.9 Million
Q2 2022

Aug 15, 2022

BUY
$5.1 - $10.0 $131,069 - $257,000
25,700 New
25,700 $177,000
Q4 2020

Feb 16, 2021

SELL
$34.9 - $51.08 $345,510 - $505,692
-9,900 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$32.95 - $50.25 $326,205 - $497,475
9,900 New
9,900 $493,000

Others Institutions Holding FMTX

About Forma Therapeutics Holdings, Inc.


  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.